Rat Leukemia Inhibitory Factor Receptor (LIFR) Protein

REQUEST MORE INFO
Catalogue No: abx067765
Price: US$261.00
(Size: 10 µg)

Click on the image to see the image legend

Available Options

* Size:






Add to Shopping Cart Buy It Now GET A QUOTE

Documents

Datasheet SDS
Rat Leukemia Inhibitory Factor Receptor (LIFR) is a recombinant Rat protein produced in a Prokaryotic expression system (E. coli).

This protein is the immunogen for the following antibodies: abx103734

Target Leukemia Inhibitory Factor Receptor (LIFR)
Origin Rat
Expression Recombinant
Tested Applications WB, SDS-PAGE
Host E. coli
Conjugation Unconjugated
Form Lyophilized
Purity > 95%
Reconstitution To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Storage Store at 2-8 °C for up to one month. Store at -80 °C for up to one year. Avoid repeated freeze/thaw cycles.
UniProt Primary AC O70535 (UniProt, ExPASy)
UniProt Entry Name LIFR_RAT
KEGG rno:81680
String 10116.ENSRNOP00000016036
Molecular Weight Calculated MW: 18.0 kDa
Sequence Fragment Lys152-Glu291
Sequence KWNDKGSAL PYPSNATWEV KVLQNPRTEP VALVSLNTVL SGKDKGHHWN WTSELPLQCA THSVSIRWHI DYPRFSGYKE WSEWSPLKNI SWTRNTETNV FPQDKVVLAG SNMTICCIST TKVLSGQIGN TFRPLIHLYG E
Tag N-terminal His tag
Buffer Prior to lyophilization: PBS, pH 7.4, containing 0.01% Sarcosyl, 1 mM DTT, 5% Trehalose and Proclin-300.
Activity Not tested
Concentration Prior to lyophilization: 200 µg/ml
Availability Shipped within 5-12 working days.
Note This product is for research use only.

Not for human consumption, cosmetic, therapeutic or diagnostic use.
Research Articles on Leukemia Inhibitory Factor Receptor (LIFR)


Write a review